DIOSNA CCS 10 in Isolator

Article

The advantages of the compact design and ease of use of Diosna´s pharmaceutical mixer P1-6 and fluid bed processor Midilab XP are the main reasons for integrating them in isolators when granulation equipment for high potent products at laboratory scale (approx.. 0.1 kg - 5 kg) is needed.

 

 

 

The advantages of the compact design and ease of use of Diosna´s pharmaceutical mixer P1-6 and fluid bed processor Midilab XP are the main reasons for integrating them in isolators when granulation equipment for high potent products at laboratory scale (approx.. 0.1 kg - 5 kg) is needed. Mixing and granulating of high potent powders with an occupational exposure limit (OEL) under 0.1 µg/m³ is then possible. The isolators are airtight and operate under negative pressure. The transfer of the high potent products is performed with rapid transfer ports or endless liner systems. After production the decontamination is achieved by WIP (washing in place) to avoid cross-contamination and hazards for the operators.


For the integration of granulation equipment in an isolator the entire process must be considered for the design of the system. For this reason a mock-up study in which all process steps are “played out” is necessary.

 

Contact Details:

DIOSNA Dierks & Söhne GmbH
Website: www.diosna.comE-mail: info@diosna.de

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Leroy Hood, MD, PhD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Related Content